Shayne Taker - Ravenquest Biomed Head Procurement
Insider
Shayne Taker is Head Procurement of Ravenquest Biomed
| Phone | 877-282-1586 |
| Web | https://www.rqbglobal.com |
Ravenquest Biomed Management Efficiency
The company has return on total asset (ROA) of (0.1885) % which means that it has lost $0.1885 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1246) %, meaning that it generated substantial loss on money invested by shareholders. Ravenquest Biomed's management efficiency ratios could be used to measure how well Ravenquest Biomed manages its routine affairs as well as how well it operates its assets and liabilities. RavenQuest BioMed Inc., a cannabis company, focuses on the cannabis production, management services and consulting, and specialized research and development activities. RavenQuest BioMed Inc. was incorporated in 1987 and is based in Vancouver, Canada. RAVENQUEST BIOMED operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. Ravenquest Biomed [RVVQF] is a Pink Sheet which is traded between brokers as part of OTC trading.Management Performance
| Return On Equity | -1.12 | |||
| Return On Asset | -0.19 |
Ravenquest Biomed Leadership Team
Elected by the shareholders, the Ravenquest Biomed's board of directors comprises two types of representatives: Ravenquest Biomed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ravenquest. The board's role is to monitor Ravenquest Biomed's management team and ensure that shareholders' interests are well served. Ravenquest Biomed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ravenquest Biomed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mathieu Mcdonald, Head Communications | ||
| Shayne Taker, Head Procurement | ||
| Andy Schinke, Head Acquisition | ||
| George Robinson, Pres CEO | ||
| CPA CGA, Chief Officer | ||
| Marla Ritchie, Corporate Secretary |
Ravenquest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ravenquest Biomed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.12 | |||
| Return On Asset | -0.19 | |||
| Operating Margin | (9.06) % | |||
| Current Valuation | 11.72 M | |||
| Shares Outstanding | 123.62 M | |||
| Shares Owned By Insiders | 10.51 % | |||
| Shares Owned By Institutions | 3.22 % | |||
| Price To Book | 0.03 X | |||
| Price To Sales | 0.03 X | |||
| Revenue | 1.26 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Ravenquest Pink Sheet
Ravenquest Biomed financial ratios help investors to determine whether Ravenquest Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ravenquest with respect to the benefits of owning Ravenquest Biomed security.